Association Between Atopic Dermatitis and Aging: Clinical Observations and Underlying Mechanisms

Peng-Yu Chen,Minxue Shen,Sui-Qing Cai,Zhen-Wei Tang

DOI: https://doi.org/10.2147/jir.s467099

IF: 4.5

2024-05-29

Journal of Inflammation Research

Abstract:Peng-Yu Chen, 1 Minxue Shen, 2– 4 Sui-Qing Cai, 1 Zhen-Wei Tang 1 1 Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China; 2 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China; 3 Hunan Engineering Research Center of Skin Health and Disease; Hunan Key Laboratory of Skin Cancer and Psoriasis (Xiangya Hospital), Changsha, 410008, People's Republic of China; 4 Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, 410078, People's Republic of China Correspondence: Zhen-Wei Tang; Sui-Qing Cai, Email ; As one of the most prevalent chronic inflammatory skin diseases, atopic dermatitis (AD) increasingly affects the aging population. Amid the ongoing global aging trend, it's essential to recognize the intricate relationship between AD and aging. This paper reviews existing knowledge, summarizing clinical observations of associations between AD and aging-related diseases in various systems, including endocrine, cardiovascular, and neurological. Additionally, it discusses major theories explaining the correlation, encompassing skin-mucosal barriers, systemic inflammation and stress, genes, signal transduction, and environmental and behavioral factors. The association between AD and aging holds significant importance, both in population and basic perspectives. While further research is warranted, this paper aims to inspire deeper exploration of inflammation/allergy-aging dynamics and the timely management of elderly patients with AD. Keywords: atopic dermatitis, aging, age-related diseases, clinical observations, mechanical theories Atopic dermatitis (AD) stands as the predominant chronic inflammatory skin condition, representing a significant health burden among non-fatal skin diseases. 1 The onset and progression of AD are largely influenced by the complex interaction between environmental factors, neuro-immune responses, and skin barrier integrity. 2 Characterized by recurrent eczematous lesions and severe itching, AD significantly impairs quality of life. 1 Recognizing the variability in clinical manifestations across the lifespan, AD is traditionally divided into three age-based categories: infancy, childhood, and adolescence/adulthood. Recent empirical research has identified a distinct subtype of AD that affects the elderly, often manifesting lichenified eczema around the typically uninvolved flexural areas of the elbows and knees. 3,4 Dupilumab has shown rapid efficacy for this phenotype. 5 The distinctions between elderly AD and classic AD are elucidated in Table 1. Table 1 The Differences Between Elderly AD and Classic AD Figure 1 Clinical observations of the possible relationship between AD and aging. Figure 2 Potential mechanisms underlying the association between AD and aging. Figure 3 The network of representative mechanisms connecting AD and aging Red lines represent promotion, and green lines represent inhibition. Abbreviations : AD, atopic dermatitis; PM, particulate matter; TEWL, transepidermal water loss; SA, Staphylococcus aureus; SE, Staphylococcus epidermidis; IL, interleukin; MMP, matrix metalloproteinase; TSLP, thymic stromal lymphopoietin; DCs, dendritic cells; ILC2s, activate group 2 innate lymphoid cells; hBDs, human beta-defensins; Dbn1, drebrin 1; ROS, reactive oxygen species; HLA, human leukocyte antigen; TRPV1, transient receptor potential vanilloid. AD has seen a marked rise in global prevalence and incidence, 12 with up to 10% of adults affected. 13 Small-scale studies indicate significant international variation in AD prevalence among the elderly, ranging from 1.6% to 4%, and increasing with age. 1,14–19 However, it's crucial to note that the reported prevalence may underestimate the true impact, due to factors such as limited healthcare access for seniors, especially in underserved regions, and diagnostic challenges that can lead to AD being obscured or misdiagnosed. Aging once deemed an inevitable aspect of the life cycle, is now understood to be a dynamic and modifiable biological process. 20 Globally, the population aged 65 and over is rising, with forecasts predicting a continued increase, surpassing 14% of the global population by 2040. 14 These demographic transformations present both opportunities and challenges for the study of age-related maladies and their biological foundations, a field that is already evolving and expected to grow. AD demonstrates a biological connection with the aging proc -Abstract Truncated-

immunology